{
    "nct_id": "NCT06555562",
    "official_title": "Activating the Cholinergic Anti-Inflammatory Pathway with Focused Ultrasound Stimulation in Healthy Volunteers and People with Inflammatory Arthritis",
    "inclusion_criteria": "* 22-75 years of age\n* Weigh at least 40 kg\nHealthy volunteers allowed\nMust have minimum age of 22 Years\nMust have maximum age of 75 Years",
    "exclusion_criteria": "* Any physical disabilities, conditions, or diseases that limit the capacity to participate in study procedures or increase the risk of harm as determined by the study PI\n* Unable to provide informed consent\n* Active bacterial or viral infection\n* Class II obesity with a BMI of 35 or higher\n* Pregnant women or those trying to become pregnant\n* Active use of tobacco/nicotine products\n* History of substance use disorder or active regular use of substances (nicotine, marijuana, cocaine, psychedelics, stimulants, etc.)\n* Splenomegaly, asplenia, or splenectomy\n\nInflammatory Arthritis Population\n\nInclusion Criteria:\n\n* 22-75 years of age\n* Weigh at least 40 kg\n* Diagnosis of Rheumatoid Arthritis, Psoriatic Arthritis, or Axial Spondyloarthritis of at least 6 months duration as defined by ACR guidelines\n* Able to continue the same stable dose of immunomodulatory medication(s) while participating in the study\n\nExclusion Criteria:\n\n* Unable to provide informed consent\n* Took a JAK inhibitor within the last 4 weeks, or likely to start one while participating in this study\n* Started a conventional synthetic DMARD (csDMARD) within the last 8 weeks or had a change in prescription within the last 4 week\n* Started a Tumor Necrosis Factor (TNF) inhibitor within the last 5 months or had a change in prescription within the last 3 months\n* Started any other biologic or targeted synthetic DMARD within the last 3 months, or likely to start one while participating in the study\n* Started a corticosteroid, had a change in prescription, or on a stable dose = or > 10 mg of prednisone daily within the last 4 weeks\n* Regular use of epinephrine like medications (cold, cough, congestion, or sinus medications, bronchodilators, appetite suppressants)\n* Active use of tobacco/nicotine products\n* History of substance use disorder or likely use of substances during the study period (marijuana, opioids/heroin, cocaine, psychedelics, methamphetamine, etc.)\n* Active bacterial or viral infection\n* Receiving chemotherapy or immunotherapy to treat malignancy\n* Significant immunodeficiency due to underlying illness\n* Class II obesity with a BMI of 35 or higher\n* Pregnant women or those trying to become pregnant\n* Wound, rash, infection, or traumatic injury over the target area\n* Vagal nerve injury or vagotomy\n* Surgery or major traumatic injury in the past 90 days\n* Chronically-implanted medical devices (i.e. pacemaker, AICD, vagus nerve stimulator, spinal cord stimulator)\n* Clinically significant cardiovascular disease\n* CKD Stage 3 or higher\n* Uncontrolled fibromyalgia or other diffuse pain syndromes",
    "miscellaneous_criteria": "Healthy Volunteer Population"
}